LifeSciences BC > News > Member Announcements > 2015 > Aquinox Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference

Member Announcements

Aquinox Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care
Conference

February 23, 2015 – Aqunox

February 23, 2015
Aquinox Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care
Conference
VANCOUVER, British Columbia, Feb. 23, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”)
(Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas
of inflammation and immuno-oncology, announced today that David Main, Aquinox’s President & CEO, will present a corporate
overview at the upcoming Cowen and Company 35th Annual Health Care Conference on Wednesday, March 4th at 8:00 AM
Eastern Time. The conference will take place at the Boston Marriott Copley Place Hotel in Boston, MA.
A live audio webcast and archive of the event will be available at: http://wsw.com/webcast/cowen22/aqxp
To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled
start time. An archived version of the webcast will also be available on the Investor Relations page of Aquinox’s website for at
least two weeks following the presentation.
The corporate overview being presented will be available at www.aqxpharma.com.
About Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in
disease areas of inflammation and immuno-oncology. Aquinox’s lead drug candidate, AQX-1125, is a small molecule activator
of SHIP1 suitable for oral, once daily dosing. Having successfully completed multiple preclinical studies and clinical trials with
AQX-1125, Aquinox is now advancing through Phase 2 development. Aquinox has a broad intellectual property portfolio and
pipeline of preclinical drug candidates that activate SHIP1. For more information, please visit www.aqxpharma.com.
Investor Contact Info:
Brendan Payne
Senior Manager, Investor Relations
Aquinox Pharmaceuticals, Inc.
604.629.9223 Ext. 109

ir@aqxpharma.com
Communications Contact Info:
Bianca Nery
Senior Account
MacDougall Biomedical Communications
650.339.7533
aquinox@macbiocom.com